Japan Anterior Uveitis Treatment Market Size & Outlook
Japan anterior uveitis treatment market, 2018-2030 (US$M)
Related Markets
Japan anterior uveitis treatment market highlights
- The Japan anterior uveitis treatment market generated a revenue of USD 34.7 million in 2022 and is expected to reach USD 65.3 million by 2030.
- The Japan market is expected to grow at a CAGR of 8.2% from 2023 to 2030.
- In terms of segment, non-infectious uveitis was the largest revenue generating type in 2022.
- Non-Infectious Uveitis is the most lucrative type segment registering the fastest growth during the forecast period.
Anterior uveitis treatment market data book summary
| Market revenue in 2022 | USD 34.7 million |
| Market revenue in 2030 | USD 65.3 million |
| Growth rate | 8.2% (CAGR from 2022 to 2030) |
| Largest segment | Non-infectious uveitis |
| Fastest growing segment | Non-Infectious Uveitis |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Uveitis, Non-Infectious Uveitis |
| Key market players worldwide | Novartis AG ADR, Santen Pharmaceutical Co Ltd, AbbVie Inc, Kiora Pharmaceuticals Inc, Clearside Biomedical Inc, Aldeyra Therapeutics Inc, UCB SA, Aciont, Sirion Therapeutics, Lux Biosciences |
Other key industry trends
- In terms of revenue, Japan accounted for 8.6% of the global anterior uveitis treatment market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan anterior uveitis treatment market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 65.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anterior Uveitis Treatment Market Scope
Anterior Uveitis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan anterior uveitis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anterior uveitis treatment market will help companies and investors design strategic landscapes.
Non-infectious uveitis was the largest segment with a revenue share of 65.71% in 2022. Horizon Databook has segmented the Japan anterior uveitis treatment market based on infectious uveitis, non-infectious uveitis covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Japan anterior uveitis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan anterior uveitis treatment market databook
-
Our clientele includes a mix of anterior uveitis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan anterior uveitis treatment market , including forecasts for subscribers. This country databook contains high-level insights into Japan anterior uveitis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan anterior uveitis treatment market size, by type, 2018-2030 (US$M)
Japan Anterior Uveitis Treatment Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
